Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance

15 Aug 2017

Abstract excerpt

Healthcare delivery has advanced due to the implementation of point-of-care testing, which is often performed within minutes to hours in minimally equipped laboratories or at home. Technologic advances are leading to point-of-care kits that incorporate nucleic acid-based assays, including polymerase chain reaction, isothermal amplification, ligation, and hybridization reactions. As a limited number of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29040621
DOI: 10.1093/infdis/jix413

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug ResistancePMID 29040621Read ↗

An overview of the human immunodeficiency virus featuring laboratory testing for drug resistance.Semantic proximity Read ↗

The use of human immunodeficiency virus resistance tests in clinical practice.Semantic proximity Read ↗

Human immunodeficiency virus drug resistance testing: state of the art in genotypic and phenotypic testing of antiretrovirals.Semantic proximity Read ↗

HIV drug resistance and you. Using resistance testing in clinical practice. U.S. guidelines, cost, limitations--and usefulness.Semantic proximity Read ↗

Developments in integrating nucleic acid isothermal amplification and detection systems for point-of-care diagnosticsSemantic proximity Read ↗

Molecular assays for monitoring HIV infection and antiretroviral therapySemantic proximity Read ↗

European recommendations for the clinical use of HIV drug resistance testing: 2011 update.Semantic proximity Read ↗

Update on antiretroviral drug resistance testing: combining laboratory technology with patient care.Semantic proximity Read ↗

Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study.Semantic proximity Read ↗

Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?Semantic proximity Read ↗

Antiretroviral drug resistance testing.Semantic proximity Read ↗

Democratizing nucleic acid-based molecular diagnostic tests for infectious diseases at resource-limited settings – from point of care to extreme point of careSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.